Hinge Health has surged 146% YTD on strong revenue growth, expanding margins and AI-driven efficiencies, while migraine and GI care offer new growth opportunities.
Hinge Health stock soars 146% YTD, fueled by robust revenue growth, rising margins and new care programs. Can its momentum continue despite expansion risks?
First Eagle Investment Management LLC cut its position in Hinge Health Inc. (NYSE:HNGE - Free Report) by 70.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 258,184 shares of the company's stock after selling...
Alberta Investment Management Corp purchased a new position in Hinge Health Inc. (NYSE:HNGE - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 190,900 shares of the company's stock, valued a...
HNGE, which went public in May 2025, is projected to double its revenue between 2025 and 2027, and its upward earnings revisions earn Hinge Health a Zacks Rank #1 (Strong Buy).